Objective
To develop and evaluate new precision medicine therapies for cancer patients. This could involve developing new drugs that target specific genetic mutations or cancer signaling pathways, or developing new ways to deliver existing drugs more precisely.
To identify and validate new biomarkers that can be used to predict the response of cancer patients to specific treatments. This could help clinicians to choose the right treatment for each individual patient, and to avoid giving patients treatments that are unlikely to be effective or that could cause unnecessary side effects.
To develop and implement new clinical trials for precision medicine therapies in cancer. This could involve trials of new drugs, new drug combinations, or new ways to deliver existing drugs.
To make precise and precision medicine therapies more accessible and affordable for cancer patients. This could involve developing new partnerships with pharmaceutical companies, governments, and other stakeholders.
Here are some specific examples of research and innovation projects
Research and Innovations could pursue in the area of precise and precision medicine for cancer:
Developing a new drug that targets a specific genetic mutation that is common in lung cancer.
Developing a new way to deliver an existing chemotherapy drug more precisely to cancer cells, while reducing damage to healthy cells.
Identifying a new biomarker that can be used to predict the response of breast cancer patients to targeted therapy.
Conducting a clinical trial of a new combination therapy for colorectal cancer.
Developing a new program to help cancer patients manage their pain and fatigue.
Developing a new online support group for cancer patients and their families.
By pursuing these and other research and innovation projects, CMH Research and Innovations can help to improve the lives of cancer patients in India and around the world.